Biosyent(TSE:RX)
CA$17.79-0.21 (-1.17%)
TSE:RX
Biosyent Revenue
CA$17.79
At close:-0.21 (-1.17%)
Want to see TSE:RX full AI Analyst Report?
Biosyent (RX) Revenue
56 Followers
Biosyent Revenue
Biosyent had a revenue of 19.87M in the quarter ending Jun 30, 2026, with 42.89%. This bring the company's revenue in the last twelve months to 55.67M, Increased 21.08%. In the fiscal year ending Dec 31, 2025, Biosyent had annual revenue of 43.05M with 22.90% growth.
- Revenue (ttm)
- 55.67M
- Revenue Growth
- 40.91%
- P/S Ratio
- 4.67
- Revenue/Employee
- CAD 717,533
- Employees
- 60
- Market Cap
- CAD 201.18M
Revenue Chart
Biosyent Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 43.05M | 8.02M | 22.90% |
| Dec 31, 2024 | 35.03M | 3.44M | 10.89% |
| Dec 31, 2023 | 31.59M | 3.67M | 13.12% |
| Dec 31, 2022 | 27.93M | -693.03K | -2.42% |
| Dec 31, 2021 | 28.62M | 6.29M | 28.15% |
| Dec 31, 2020 | 22.33M | 907.84K | 4.24% |
| Dec 31, 2019 | 21.42M | -102.70K | -0.48% |
| Dec 31, 2018 | 21.53M | 764.27K | 3.68% |
| Dec 31, 2017 | 20.76M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

